BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19528079)

  • 1. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.
    Scoumanne A; Zhang J; Chen X
    Nucleic Acids Res; 2009 Aug; 37(15):4965-76. PubMed ID: 19528079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
    Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
    Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition.
    Scoumanne A; Chen X
    Cancer Res; 2006 Jun; 66(12):6271-9. PubMed ID: 16778203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
    Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
    J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 5 is an essential component of the hypoxia-inducible factor 1 signaling pathway.
    Lim JH; Choi YJ; Cho CH; Park JW
    Biochem Biophys Res Commun; 2012 Feb; 418(2):254-9. PubMed ID: 22266372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.
    Tian Y; Yang W; Yang R; Zhang Q; Hao L; Bian E; Yang Y; Huang X; Wu Y; Zhang B
    Toxicol Appl Pharmacol; 2022 Jan; 435():115829. PubMed ID: 34919946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out of the jaws of death: PRMT5 steers p53.
    Berger SL
    Nat Cell Biol; 2008 Dec; 10(12):1389-90. PubMed ID: 19043433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
    Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
    Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.
    Gerhart SV; Kellner WA; Thompson C; Pappalardi MB; Zhang XP; Montes de Oca R; Penebre E; Duncan K; Boriack-Sjodin A; Le B; Majer C; McCabe MT; Carpenter C; Johnson N; Kruger RG; Barbash O
    Sci Rep; 2018 Jun; 8(1):9711. PubMed ID: 29946150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT5 is essential for the eIF4E-mediated 5'-cap dependent translation.
    Lim JH; Lee YM; Lee G; Choi YJ; Lim BO; Kim YJ; Choi DK; Park JW
    Biochem Biophys Res Commun; 2014 Oct; 452(4):1016-21. PubMed ID: 25234597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    AbuHammad S; Cullinane C; Martin C; Bacolas Z; Ward T; Chen H; Slater A; Ardley K; Kirby L; Chan KT; Brajanovski N; Smith LK; Rao AD; Lelliott EJ; Kleinschmidt M; Vergara IA; Papenfuss AT; Lau P; Ghosh P; Haupt S; Haupt Y; Sanij E; Poortinga G; Pearson RB; Falk H; Curtis DJ; Stupple P; Devlin M; Street I; Davies MA; McArthur GA; Sheppard KE
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17990-18000. PubMed ID: 31439820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis.
    Liu F; Cheng G; Hamard PJ; Greenblatt S; Wang L; Man N; Perna F; Xu H; Tadi M; Luciani L; Nimer SD
    J Clin Invest; 2015 Sep; 125(9):3532-44. PubMed ID: 26258414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
    Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
    J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine methylation regulates the p53 response.
    Jansson M; Durant ST; Cho EC; Sheahan S; Edelmann M; Kessler B; La Thangue NB
    Nat Cell Biol; 2008 Dec; 10(12):1431-9. PubMed ID: 19011621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
    Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
    Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.
    Xu Y; Yan W; Chen X
    Oncogene; 2010 Jul; 29(28):4090-100. PubMed ID: 20473326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation.
    Lee YH; Bedford MT; Stallcup MR
    Genes Dev; 2011 Jan; 25(2):176-88. PubMed ID: 21245169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.
    Yang R; Dong S; Zhang J; Zhu S; Miao G; Zhang B
    Mol Cell Biochem; 2023 May; 478(5):1031-1044. PubMed ID: 36214894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of IARS2 Inhibited Proliferation of Acute Myeloid Leukemia Cells by Regulating p53/p21/PCNA/eIF4E Pathway.
    Li H; Tian Y; Li X; Wang B; Zhai D; Bai Y; Dong C; Chao X
    Oncol Res; 2019 Jun; 27(6):673-680. PubMed ID: 30832756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.